Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug development
Pharma
Shionogi's antiviral comes up short in global COVID-19 trial
Shionogi's antiviral ensitrelvir missed the mark in a late-stage COVID-19 trial, putting a damper on U.S. approval prospects for the drug.
Fraiser Kansteiner
May 13, 2024 10:48am
Medincell, AbbVie set out to create new long-acting injectables
Apr 17, 2024 2:49pm
AbbVie makes a case for 'big bets' in new corporate campaign
Apr 2, 2024 8:00am
'The Top Line’: Closing the $1 trillion women’s health gap
Jan 26, 2024 9:23am
Lilly teams with Redwire on orbital drug development experiments
Oct 30, 2023 2:39pm
Fierce 50 spotlight: Patient Advocacy lead Paige Minemyer
Sep 6, 2023 9:30am